- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02088580
Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients
Study Overview
Status
Intervention / Treatment
Detailed Description
Acute depression, and suicidality continue to be significant causes of morbidity and mortality, and frequently result in acute inpatient hospitalization. Currently available treatments for depression have limitations for acute care including, either a slow onset of action such as is the case of pharmacotherapy, or high cost and limited availability such as is the case for ECT. This is exacerbated by ever shortening hospitalization times. Subsequently many of the individuals who are admitted for depression are discharged weeks before it can be expected for them to have symptomatic relief. Further more, in many cases treatment results in the trial of multiple medications before an effective treatment regimen is found (if such a treatment is found at all) (Rush, Trivedi et al. 2006). There is subsequently a great need for effective anti-depressant therapies with rapid onset of action, widespread availability, and cost effectiveness.
There is a consistent and expanding body of literature showing that chronotherapy is an effective, and rapid treatment of acute depression(Wu, Kelsoe et al. 2009, Martiny, Refsgaard et al. 2012, Echizenya, Suda et al. 2013). Published studies report response and remission rates in the range of 41-61%, 24-59% respectively acutely. Chronotherapy is a brief protocol that involves the combination of wake therapy (total sleep deprivation), sleep phase advance (a shift to an earlier sleep schedule with gradual normalization), and bright light therapy. The currently published reports have demonstrated efficacy in both unipolar and bipolar depression, and there has been reported stability of results for as long as 9 weeks (which was the longest designed study). Studies have been completed in real world clinical populations, which have included co-morbid populations, with the only groups showing a worsening of effect being those with psychotic depression (Benedetti, Zanardi et al. 1999), and those with panic disorder(Roy-Byrne, Uhde et al. 1986). The treatment itself has been well tolerated with a high percentage of individuals completing the procedure.
The current body of literature is encouraging, and the technique is being utilized clinically in some facilities (including our own institution), however there are still relatively few clinical trials published, and still unanswered questions that limit widespread clinical utility. One such issue is related to the high percentage of published trials performed outside of the US (although some have been done in the US). Because a high percentage of the studies have been done in other countries it is not clear if this procedure will translate well into the treatment paradigm in the US. Currently in the US, inpatient admission is restricted to individuals with severe, often highly treatment resistant disease that includes acute suicidality. To this writers knowledge there have not been any studies that specifically address suicidality. It is also not clear if patients in the US will tolerate the procedure. Tolerability has been addressed in many of the published papers, and in general the procedure is tolerated well with few if any side effects, however, again it is unclear how the procedure would be tolerated in clinical patients in the US.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A current episode of non-psychotic major depression.
- Currently hospitalized.
- Age greater than 18.
- If bipolar illness, must not be a mixed state, and must be on a therapeutic dose of a mood stabilizer.
Exclusion Criteria:
- Urine drug screen positive for cocaine, or current alcohol abuse/dependence that requires detox.
- Current psychosis.
- Panic disorder.
- A history of seizures, uncontrolled severe headaches, stroke, or other neurologic illness that produces either gait abnormalities or a lowered seizure threshold.
- Medical illness that would make wake therapy intolerable, or significant cardiac disease.
- Cataracts, glaucoma, or other intrinsic eye condition.
- Currently taking light sensitizing medications.
- Current pregnancy which is routinely tested for prior to admission.
- Mental retardation, or dementia.
- Untreated sleep disorder such as Obstructive sleep apnea, narcolepsy, or PLMD.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Triple Chronotherapy
Total sleep deprivation, Sleep phase advance, and Bright light therapy.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hamilton Depression Rating Scale
Time Frame: Day prior to total sleep deprivation, and then again over the next 4 consecutive days.
|
Change Score of Pre and Post Hamilton depression depression scores
|
Day prior to total sleep deprivation, and then again over the next 4 consecutive days.
|
Columbia Suicide Severity Rating Scale
Time Frame: Daily throughout the treatment (Days 0-4)
|
Change score in Columbia Suicide Severity Rating Scale
|
Daily throughout the treatment (Days 0-4)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Chronotherapy Pilot
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Depression
-
University Health Network, TorontoCompletedBipolar Disorder | Bipolar Depression | Bipolar I Depression | Bipolar II DepressionCanada
-
Brigham and Women's HospitalRecruitingDepression | Bipolar Disorder | Bipolar Depression | Major Depressive Episode | Bipolar I Depression | Bipolar II DepressionUnited States
-
Forest LaboratoriesGedeon Richter Ltd.CompletedDepression, BipolarUnited States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
-
Queen's UniversityPfizer; Providence Health & Services; MDS Pharma ServicesCompletedDepression, BipolarCanada
-
Ewha Womans University Mokdong HospitalWithdrawnDepression, BipolarKorea, Republic of
-
Mclean HospitalTerminatedBipolar Depression Depressed PhaseUnited States
-
AstraZenecaCompletedAcute Bipolar DepressionBrazil, Mexico, Peru, Turkey, Argentina, Chile, Venezuela, Colombia, Guatemala
-
Valerie TaylorUniversity Health Network, TorontoActive, not recruitingBipolar DepressionCanada
-
National University of Ireland, Galway, IrelandStanley Medical Research InstituteCompletedBipolar DepressionIreland
-
Astellas Pharma IncCompleted
Clinical Trials on Triple Chronotherapy
-
Rhode Island HospitalNorthwell Health; University of North Carolina, Chapel HillRecruitingDepression | Postpartum Depression | Sleep Disturbance | Pregnancy Related | Circadian Dysregulation | Prenatal DisorderUnited States
-
Rhode Island HospitalNational Institute of Mental Health (NIMH); The Depressive and Bipolar Disorder...CompletedDepression | Postpartum Depression | Major Depressive DisorderUnited States
-
Billings ClinicCompletedSuicidal Ideation | Depressive Disorder, Major | Bipolar DepressionUnited States
-
University of California, BerkeleyCompletedEveningness/SleepUnited States
-
Northwell HealthWithdrawnHypertensionUnited States
-
Peking UniversityChina International Medical FoundationCompletedHead and Neck Cancer | Radiotherapy | Triple Pre-rehabilitationChina
-
University of ManchesterRoyal Children's HospitalCompleted
-
Sheba Medical CenterUnknown
-
University of OxfordOxford University Hospitals NHS TrustUnknown